Annis Gardner Whiting Capital Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-135
Closed -$28.5K – 473
2026
Q1
$28.5K Buy
135
+9
+7% +$1.94K ﹤0.01% 671
2025
Q4
$25.9K Buy
126
+10
+9% +$1.88K ﹤0.01% 616
2025
Q3
$18.2K Sell
116
-17
-13% -$2.63K ﹤0.01% 620
2025
Q2
$22.3K Buy
133
+38
+40% +$5.64K 0.01% 548
2025
Q1
$13.1K Hold
95
– – 0.01% 508
2024
Q4
$11.2K Buy
95
+42
+79% +$4.9K ﹤0.01% 519
2024
Q3
$5.86K Hold
53
– – ﹤0.01% 617
2024
Q2
$5.21K Hold
53
– – ﹤0.01% 771
2024
Q1
$5.96K Hold
53
– – ﹤0.01% 741
2023
Q4
$5.37K Hold
53
– – ﹤0.01% 540
2023
Q3
$4.6K Buy
+53
New +$4.79K ﹤0.01% 539

Other funds holding CAH

Annis Gardner Whiting Capital Advisors's CAH Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Cardinal Health (CAH) in Q2 2026, closing a stake of 135 shares — an estimated $28.5K sold.

Annis Gardner Whiting Capital Advisors first reported a position in CAH in Q3 2023 and held it in 11 quarters. The position peaked at $28.5K in Q1 2026. 1,500 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Cardinal Health position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 135 Cardinal Health shares in Q2 2026, an estimated $28.5K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Cardinal Health in Q3 2023 and held it in 11 quarters.
  • Annis Gardner Whiting Capital Advisors's Cardinal Health position peaked at $28.5K in Q1 2026.
  • 1,500 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.